v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities:    
Net loss $ (34,260) $ (34,140)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,516 2,946
Reduction in the carrying amount of right-of-use assets 1,561 2,517
Stock-based compensation 7,853 5,525
Asset impairment and other charges 165 0
Equity securities earned from research and development activities 0 (118)
Non-cash interest expense 345 0
Amortization of discount on short-term investments (487) 0
Other non-cash items 14 (15)
Changes in operating assets and liabilities:    
Financial assets 7,137 19,261
Inventories 453 (23)
Prepaid expenses and other assets 2,402 1,324
Accounts payable (2,275) 631
Accrued compensation and other accrued liabilities (2,598) (10,373)
Other long-term liabilities (2,022) (2,864)
Deferred revenue (761) (9,970)
Net cash used in operating activities (19,957) (25,299)
Investing activities:    
Purchase of property and equipment (1,525) (4,120)
Proceeds from sale of property and equipment 15 15
Investment in short-term investments (57,140) 0
Proceeds from maturity of short-term investments 3,000 0
Investment in non-marketable securities 0 (750)
Net cash used in investing activities (55,650) (4,855)
Financing activities:    
Proceeds from exercises of stock options 281 422
Proceeds from issuance of stock under employee stock purchase plan 327 0
Proceeds from issuance of common stock in connection with equity sales agreement 0 8,652
Costs incurred in connection with equity sales agreements (403) (395)
Proceeds from long-term debt 29,521 0
Payment of debt issuance costs (642) 0
Taxes paid related to net share settlement of equity awards 0 (404)
Net cash provided by financing activities 29,084 8,275
Net decrease in cash, cash equivalents and restricted cash (46,523) (21,879)
Cash, cash equivalents and restricted cash at the beginning of the period 66,697 116,026
Cash, cash equivalents and restricted cash at the end of the period 20,174 94,147
Supplemental disclosure of cash flow information:    
Interest paid 890 10
Income taxes paid 17 193
Supplemental non-cash investing and financing activities:    
Capital expenditures incurred but not yet paid 768 434
Transfer from property and equipment to assets held for sale 59 0
Cash reconciliation:    
Cash and cash equivalents 18,595 92,093
Restricted cash, current and non-current 1,579 2,054
Total cash, cash equivalents and restricted cash 20,174 $ 94,147
Short-term investments 54,604  
Cash, cash equivalents, and short-term investments $ 73,199  

Source

PDF HTML 10-Q Filing
ZIP XBRL